Mondelli, Valeria

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., et al. (2022) · Nature

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 2,964

Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α

Baumeister, D., Akhtar, R., Ciufolini, S., Pariante, C. M., & Mondelli, V (2016) · Molecular Psychiatry

Child Abuse and TraumaStress Responses and Cortisol

Cited by 1,084

Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue

Enache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 615

Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study

Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O'Connor, J., Russo, M., et al. (2015) · The Lancet Psychiatry

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 588

High-potency cannabis and the risk of psychosis

Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 567

Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users

Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S. A., Marconi, A., La Cascia, C., Reis Marques, T., Pariante, C., et al. (2014) · Schizophrenia Bulletin

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 470

Treatment-resistant depression and peripheral C-reactive protein.

Chamberlain, S. R., Cavanagh, J., de Boer, P., Mondelli, V., Jones, D. N. C., Drevets, W. C., Cowen, P. J., Harrison, N. A., Pointon, L., Pariante, C. M., et al. (2019) · British Journal of Psychiatry

Tryptophan and brain disordersTreatment of Major Depression

Cited by 400

The HPA axis in bipolar disorder: Systematic review and meta-analysis

Belvederi Murri, M., Prestia, D., Mondelli, V., Pariante, C., Patti, S., Olivieri, B., Arzani, C., Masotti, M., Respino, M., Antonioli, M., et al. (2016) · Psychoneuroendocrinology

Bipolar Disorder and TreatmentStress Responses and Cortisol

Cited by 391

HPA axis and aging in depression: Systematic review and meta-analysis

Belvederi Murri, M., Pariante, C., Mondelli, V., Masotti, M., Atti, A. R., Mellacqua, Z., Antonioli, M., Ghio, L., Menchetti, M., Zanetidou, S., et al. (2014) · Psychoneuroendocrinology

Stress Responses and CortisolAdrenal Hormones and Disorders

Cited by 367

Stress sensitivity, aberrant salience, and threat anticipation in early psychosis: An experience sampling study

Reininghaus, U., Kempton, M. J., Valmaggia, L., Craig, T. K. J., Garety, P., Onyejiaka, A., Gayer-Anderson, C., So, S. H., Hubbard, K., Beards, S., et al. (2016) · Schizophrenia Bulletin

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 304

Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses

Lally, J., Ajnakina, O., Di Forti, M., Trotta, A., Demjaha, A., Kolliakou, A., Mondelli, V., Reis Marques, T., Pariante, C., Dazzan, P., et al. (2016) · Psychological Medicine

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 298

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

Mondelli, V., Ciufolini, S., Belvederi Murri, M., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T. R., Zunszain, P. A., Morgan, C., Murray, R. M., et al. (2015) · Schizophrenia Bulletin

Schizophrenia research and treatmentTryptophan and brain disorders

Cited by 286

Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment

Mondelli, V., Dazzan, P., Hepgul, N., Di Forti, M., Aas, M., D'Albenzio, A., Di Nicola, M., Fisher, H., Handley, R., Marques, T. R., et al. (2010) · Schizophrenia Research

Stress Responses and CortisolSchizophrenia research and treatment

Cited by 278

Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan

Martland, R., Mondelli, V., Gaughran, F., & Stubbs, B. (2020) · Journal of Sports Sciences

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 253

Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies

Chang, J. P.-C., Su, K.-P., Mondelli, V., & Pariante, C. M. (2018) · Neuropsychopharmacology

Fatty Acid Research and HealthAttention Deficit Hyperactivity Disorder

Cited by 248

Genetic Contributions of Inflammation to Depression

Barnes, J., Mondelli, V., & Pariante, C. M. (2017) · Neuropsychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 237

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice

Mancuso, R., Fryatt, G., Cleal, M., Obst, J., Pipi, E., Monzón-Sandoval, J., Ribe, E., Winchester, L., Webber, C., Nevado, A., et al. (2019) · Brain

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 235

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial

Nettis, M. A., Lombardo, G., Hastings, C., Zajkowska, Z., Mariani, N., Nikkheslat, N., Worrell, C., Enache, D., McLaughlin, A., Kose, M., et al. (2021) · Neuropsychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 235

Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users

Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 234

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation

Aas, M., Dazzan, P., Mondelli, V., Melle, I., Murray, R. M., & Pariante, C. M. (2014) · Frontiers in Psychiatry

Schizophrenia research and treatmentDementia and Cognitive Impairment Research

Cited by 230

Serum and gene expression profile of cytokines in first-episode psychosis

Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K. J., Janiri, L., Murray, R. M., Dazzan, P., Pariante, C. M., & Mondelli, V. (2013) · Brain Behavior and Immunity

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 217

A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis

Pillinger, T., Osimo, E. F., Brugger, S., Mondelli, V., McCutcheon, R. A., & Howes, O. D. (2019) · Schizophrenia Bulletin

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 190

Peripheral Blood Cell–Stratified Subgroups of Inflamed Depression

Lynall, M.-E., Turner, L., Bhatti, J., Cavanagh, J., de Boer, P., Mondelli, V., Jones, D., Drevets, W. C., Cowen, P., Harrison, N. A., et al. (2020) · Biological Psychiatry

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 187

Effects of psychotropic drugs on inflammation:Consequence or mediator of therapeutic effects in psychiatric treatment?

Baumeister, D., Ciufolini, S., & Mondelli, V. (2016) · Psychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 183